Inside Remdesivir puzzle: 6 producers, little supply!
Demand fell to almost nil by January after the first wave of the pandemic in the country. Since there was no demand, most manufacturers stopped giving fresh orders for manufacturing
PB Jayakumar | May 3, 2021 | Updated 19:22 IST
Demand for Remdesivir fell to almost nil by January after the first wave of the pandemic in the country
Reduction in production due to less demand after the first wave of coronavirus and lack of vigil on the part of the Government to ensure stockpiling led to current Remdesivir crisis, say sources.
Gilead Life Sciences, the innovator of the re-purposed drug, had licensed six manufacturers in India to produce the drug. Most of them were dependent on contract manufacturers and their subsidiaries to make the product. Demand fell to almost nil by January after the first wave of the pandemic in the country. Since there was no demand, most manufacturers stopped giving fresh orders for manufacturing. Neith
Ninety Patients in Maharashtra Suffer Side-effects of Remdesivir by Angela Mohan on May 3, 2021 at 8:52 AM
Remdesivir produced severe side-effects in Maharashtra. The state government imposed a temporary suspension on its use, says FDA Minister Rajendra Shingane. The incident took place on Thursday in three hospitals in the district. The patients who were administered Remdesivir manufactured by the company Hetero Drugs had complained of side-effects, Shingane told IANS.
The shocking incident came to light when some patients developed chills and others complained of varying degrees of fever or other issues which were immediately addressed by the district medical authorities. The situation is under control and the condition of all the patients is stable now. There is no cause for worry, the minister assured.
Covid-19: Why is there a shortage of Remdesivir?- Business News businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.
Maha: Mega scare as 90 suffer Remdesivir side-effects, brand suspended
Sparking a mega health scare, at least 90 COVID-19 patients in Maharashtra’s Raigad district, who were administered Remdesivir doses of a particular brand, developed severe side-effects following which the state government has imposed a temporary suspension on its use here, FDA Minister Rajendra Shingane said.
| 1 May 2021 5:03 AM GMT
RAIGAD/MUMBAI: Sparking a mega health scare, at least 90 COVID-19 patients in Maharashtra s Raigad district, who were administered Remdesivir doses of a particular brand, developed severe side-effects following which the state government has imposed a temporary suspension on its use here, FDA Minister Rajendra Shingane said.